Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med. 2022;386:157–71.

Article  CAS  PubMed  Google Scholar 

El-Husseini ZW, Gosens R, Dekker F, Koppelman GH. The genetics of asthma and the promise of genomics-guided drug target discovery. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30363-5.

Article  PubMed  Google Scholar 

Garbers C, Monhasery N, Aparicio-Siegmund S, Lokau J, Baran P, Nowell MA, Jones SA, Rose-John S, Scheller J. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases. Biochim Biophys Acta. 2014;1842:1485–94.

Article  CAS  PubMed  Google Scholar 

Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, Gao P, Saleheen D, Rendon A, Nelson CP, Braund PS, Hall AS, Chasman DI, Tybjærg-Hansen A, Chambers JC, Benjamin EJ, Franks PW, Clarke R, Wilde AAM, Trip MD, Steri M, Witteman JCM, Qi L, van der Schoot CE, de Faire U, Erdmann J, Stringham HM, Koenig W, Rader DJ, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (London, England). 2012;379:1205–13.

Article  PubMed  Google Scholar 

Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JEL, Shah T, Sofat R, Guo Y, Chung C, Peasey A, Pfister R, Mooijaart SP, Ireland HA, Leusink M, Langenberg C, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Hardy J, Nalls MA, Li YR, Lowe G, Stewart M, Bielinski SJ, Peto J, Timpson NJ, Gallacher J, Dunlop M, et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (London, England). 2012;379:1214–24.

Article  PubMed  Google Scholar 

Yokoyama A, Kohno N, Fujino S, Hamada H, Inoue Y, Fujioka S, Ishida S, Hiwada K. Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med. 1995;151:1354–8.

Article  CAS  PubMed  Google Scholar 

Neveu WA, Allard JL, Raymond DM, Bourassa LM, Burns SM, Bunn JY, Irvin CG, Kaminsky DA, Rincon M. Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res. 2010;11:1–10.

Article  Google Scholar 

Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Holguin F, Wenzel SE, Woodruff PG, Bleecker ER, Fahy JV. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4:574–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Virchow JC, Kroegel C, Walker C, Matthys H. Inflammatory determinants of asthma severity: Mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. J Allergy Clin Immunol. 1996;98:S27–40.

Article  PubMed  Google Scholar 

Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003;149:1–38.

CAS  PubMed  Google Scholar 

Matthews V, Schuster B, Schütze S, Bussmeyer I, Ludwig A, Hundhausen C, Sadowski T, Saftig P, Hartmann D, Kallen KJ, Rose-John S. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem. 2003;278:38829–39.

Article  CAS  PubMed  Google Scholar 

Horiuchi S, Koyanagiu Y, Zhouu Y, Miyamotou H, Tanakau Y, Waki M, Matsumoto A, Yamamotou M, Yamamotof N. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol. 1994;24:1945–8.

Article  CAS  PubMed  Google Scholar 

Garbers C, Heink S, Korn T, Rose-John S. Interleukin-6: designing specific therapeutics for a complex cytokine. Nat Rev Drug Discov. 2018;17:395–412.

Article  CAS  PubMed  Google Scholar 

Zuyderduyn S, Ninaber DK, Schrumpf JA, van Sterkenburg MAJA, Verhoosel RM, Prins FA, van Wetering S, Rabe KF, Hiemstra PS. IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides. Respir Res. 2011;12:1–12.

Article  Google Scholar 

Kistemaker LEM, Hiemstra PS, Bos IST, Bouwman S, Van Den Berge M, Hylkema MN, Meurs H, Kerstjens HAM, Gosens R. Tiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cells. Thorac Surg Clin. 2015;70:668–76.

Google Scholar 

BEAS-2B Cell Line human | Sigma-Aldrich. <https://www.sigmaaldrich.com/NL/en/product/sigma/95102433?gclid=EAIaIQobChMIrOv8nu_A_gIVGsh3Ch3A2wb_EAAYASAAEgJeG_D_BwE&gclsrc=aw.ds>.

Schreiber S, Aden K, Bernardes JP, Conrad C, Tran F, Höper H, Volk V, Mishra N, Blase JI, Nikolaus S, Bethge J, Kühbacher T, Röcken C, Chen M, Cottingham I, Petri N, Rasmussen BB, Lokau J, Lenk L, Garbers C, Feuerhake F, Rose-John S, Waetzig GH, Rosenstiel P. Therapeutic Interleukin-6 trans-signaling inhibition by Olamkicept (sgp130Fc) in patients with active inflammatory bowel disease. Gastroenterology. 2021;160:2354-2366.e11.

Article  CAS  PubMed  Google Scholar 

Jostock T, Müllberg J, Özbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem. 2001;268:160–7.

Article  CAS  PubMed  Google Scholar 

Garbers C, Thaiss W, Jones GW, Waetzig GH, Lorenzen I, Guilhot F, Lissilaa R, Ferlin WG, Grötzinger J, Jones SA, Rose-John S, Scheller J. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. J Biol Chem. 2011;286:42959–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin M, Rose-John S, Grötzinger J, Conrad U, Scheller J. Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling. Biochem J. 2006;398:577–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lokau J, Kleinegger F, Garbers Y, Waetzig GH, Grötzinger J, Rose-John S, Haybaeck J, Garbers C. Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells. PLoS One. 2020;15:e0232612.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Merck. Millicell ® ERS-2 Electrical Resistance System User Guide. at <www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/407/335/00108103w-mk.pdf>.

Jayalatha AKS, Badi Y, Ketelaar M, Hesse L, Kermani NZ, Meyer K, Van Den BM, Guryev V, Adcock I, Koppelman G, Nawijn M. Gene signature for patient stratification: lessons learned from IL-33 stimulated TH2 genes. ERJ Open Res. 2022;8:114.

Google Scholar 

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–50.

Article  CAS  PubMed  Google Scholar 

Jevnikar Z, Östling J, Ax E, Calvén J, Thörn K, Israelsson E, Öberg L, Singhania A, Lau LCK, Wilson SJ, Ward JA, Chauhan A, Sousa AR, De Meulder B, Loza MJ, Baribaud F, Sterk PJ, Chung KF, Sun K, Guo Y, Adcock IM, Payne D, Dahlen B, Chanez P, Shaw DE, Krug N, Hohlfeld JM, Sandström T, Djukanovic R, et al. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation. J Allergy Clin Immunol. 2019;143:577–90.

Article  CAS  PubMed  Google Scholar 

Vermeulen CJ, Xu CJ, Vonk JM, ten Hacken NHT, Timens W, Heijink IH, Nawijn MC, Boekhoudt J, van Oosterhout AJ, Affleck K, Weckmann M, Koppelman GH, van den Berge M. Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission. Eur Respir J. 2020;55:1–10.

Article  Google Scholar 

Boudewijn IM, Faiz A, Steiling K, van der Wiel E, Telenga ED, Hoonhorst SJM, ten Hacken NHT, Brandsma CA, Kerstjens HAM, Timens W, Heijink IH, Jonker MR, de Bruin HG, Sebastiaan Vroegop J, Pasma HR, Boersma WG, Wielders P, van den Elshout F, Mansour K, Spira A, Lenburg ME, Guryev V, Postma DS, van den Berge M. Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression. Respir Res. 2017;18:213.

Article  PubMed  PubMed Central  Google Scholar 

Kole TM, Vanden Berghe E, Kraft M, Vonk JM, Nawijn MC, Siddiqui S, Sun K, Fabbri LM, Rabe KF, Chung KF, Nicolini G, Papi A, Brightling C, Singh D, van der Molen T, Dahlén SE, Agusti A, Faner R, Wedzicha JA, Donaldson GC, Adcock IM, Lahousse L, Kerstjens HAM, van den Berge M, Badorrek P, Broeders M, Boersma WG, Chetta A, Cukier A, et al. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study. Lancet Respir Med. 2023;11:55–64.

Article  PubMed  Google Scholar 

Postma DS, Brightling C, Baldi S, Van den Berge M, Fabbri LM, Gagnatelli A, Papi A, Van der Molen T, Rabe KF, Siddiqui S, Singh D, Nicolini G, Kraft M, Pizzichini E, Cukier A, Stelmach R, Olivenstein R, Zhang Q, Badorrek P, Gessner C, Scichilone N, Chetta A, Paggiaro P, Milleri S, D’Amato M, Spanevello A, Foschino MP, Boersma WG, Broeders M, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med. 2019;7:402–16.

Article  PubMed  Google Scholar 

Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci. 2012;8:1281.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hawkins GA, Robinson MB, Hastie AT, Li X, Li H, Moore WC, Howard TD, Busse WW, Erzurum SC, Wenzel SE, Peters SP, Meyers DA, Bleecker ER. The IL6R variation Asp358Ala is a potential modifier of lung function in subjects with asthma. J Allergy Clin Immunol. 2012;130:510–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Francisco D, Wang Y, Conway M, Hurbon AN, Dy ABC, Addison KJ, Chu HW, Voelker DR, Ledford JG, Kraft M. Surfactant Protein-A protects against IL-13-induced inflammation in asthma. J Immunol. 2020;204:2829.

Article  CAS  PubMed  Google Scholar 

Winslow S, Odqvist L, Diver S, Riise R, Abdillahi S, Wingren C, Lindmark H, Wellner A, Lundin S, Yrlid L, Ax E, Djukanovic R, Sridhar S, Higham A, Singh D, Southworth T, Brightling CE, Olsson HK, Jevnikar Z. Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD. Eur Respir J. 2021;58:15835.

Article  Google Scholar 

Jayalatha AS, Ketelaar M, Hesse L, Badi Y, Zounemat-Kermani N, Brouwer S, Dijk F, van den Berge M, Guryev V, Sayers I, Vonk J, Adcock I, Koppelman G, Nawijn M. IL-33 induced gene expression in activated Th2 effector cells is dependent on IL-1RL1 haplotype and disease status. bioRxiv. 2